No photo of Giorgio Valabrega

View Scopus Profile

Giorgio Valabrega

20032019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Giorgio Valabrega is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Platinum Medicine & Life Sciences
Adoptive Immunotherapy Medicine & Life Sciences
Endometrial Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

Author Correction: Modeling ErbB2-p130Cas interaction to design new potential anticancer agents

Costamagna, A., Rossi Sebastiano, M., Natalini, D., Simoni, M., Valabrega, G., Defilippi, P., Visentin, S., Ermondi, G., Turco, E., Caron, G. & Cabodi, S., Nov 22 2019, In : Scientific Reports. 9, 1, p. 17729

Research output: Contribution to journal › Article

Antineoplastic Agents

CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy

Rotolo, R., Leuci, V., Donini, C., Cykowska, A., Gammaitoni, L., Medico, G., Valabrega, G., Aglietta, M. & Sangiolo, D., Jun 11 2019, In : International Journal of Molecular Sciences. 20, 11

Research output: Contribution to journal › Review article

Adoptive Immunotherapy
Antigen Receptors
T-cells
lymphocytes
antigens

Endometrial Cancer Stem Cells: Role, Characterization and Therapeutic Implications

Giannone, G., Attademo, L., Scotto, G., Genta, S., Ghisoni, E., Tuninetti, V., Aglietta, M., Pignata, S. & Valabrega, G., Nov 19 2019, In : Cancers. 11, 11

Research output: Contribution to journal › Review article

Neoplastic Stem Cells
Endometrial Neoplasms
Therapeutics
Octamer Transcription Factors
Catenins

Is there a role for immunotherapy in ovarian cancer?

Giannone, G. & Valabrega, G., Dec 2019, In : Annals of Translational Medicine. 7, Suppl 8, p. S276

Research output: Contribution to journal › Article

Modeling ErbB2-p130Cas interaction to design new potential anticancer agents

Costamagna, A., Rossi Sebastiano, M., Natalini, D., Simoni, M., Valabrega, G., Defilippi, P., Visentin, S., Ermondi, G., Turco, E., Caron, G. & Cabodi, S., Feb 28 2019, In : Scientific Reports. 9, 1, p. 3089

Research output: Contribution to journal › Article

Antineoplastic Agents
Breast Neoplasms
Nodal Protein
Cell Proliferation
Receptor Protein-Tyrosine Kinases